Home › Cancro metastatico › Wisconsin › Madison
Studi clinici su Cancro metastatico a Madison, WI
21 studi su Cancro metastatico cercano partecipanti presso sedi a Madison e dintorni (entro circa 30 miglia). Apri uno studio per vedere chi può partecipare e come contattare il team.
Testo ufficiale dello studio (inglese)
Stai reclutando per uno studio? Mettilo in evidenza in cima alla pagina — $99 per 30 giorni →
Targeted Therapy Directed by Genetic Testing in Treating Patients With Locally Advanced or Advanced Solid Tumors, The ComboMATCH Screening Trial
In reclutamentoFase 2
- University of Wisconsin Carbone Cancer Center - Eastpark Medical Center, Madison
- University of Wisconsin Carbone Cancer Center - University Hospital, Madison
The Evaluation of PC14586 in Patients With Advanced Solid Tumors Harboring a TP53 Y220C Mutation (PYNNACLE)
In reclutamentoFase 1/2
- University of Wisconsin Carbone Cancer Center, Madison
Atebimetinib + GnP as a First Line Treatment in Patients With Metastatic Pancreatic Adenocarcinoma
In reclutamentoFase 3
- University of Wisconsin Carbone Cancer Center, Madison
Testing the Safety and Tolerability of the Anti-cancer Drugs Trastuzumab Deruxtecan and Neratinib for Cancers With Changes in the HER2 Gene
In reclutamentoFase 1
- University of Wisconsin Carbone Cancer Center - Eastpark Medical Center, Madison
- University of Wisconsin Carbone Cancer Center - University Hospital, Madison
A Study of HC-7366 in Combination With Belzutifan (WELIREG™) in Patients With Renal Cell Carcinoma
In reclutamentoFase 1
- University of Wisconsin - Carbone Cancer Center, Madison
Open-Label Study of BBO-10203 in Subjects With Advanced Solid Tumors
In reclutamentoFase 1
- Wisconsin Institute for Medical Research, Madison
A Study of ASP3082 in Adults With Advanced Solid Tumors
In reclutamentoFase 1
- University of Wisconsin Hospital, Madison
A Three-Part Phase 3 Study of Sofetabart Mipitecan in Participants With Platinum-Resistant (Part A) and Platinum-Sensitive (Parts B and C) Ovarian Cancer
In reclutamentoFase 3
- University of Wisconsin Carbone Cancer Center - University Hospital, Madison
A Study of First-Line Olomorasib (LY3537982) and Pembrolizumab With or Without Chemotherapy in Patients With Advanced KRAS G12C-Mutant Non-small Cell Lung Cancer
In reclutamentoFase 3
- SSM Health Dean Medical Group - South Madison Campus Health Research/Circuit Clinical, Madison
Personalized Antibody-Drug Conjugate Therapy Based on RNA and Protein Testing for the Treatment of Advanced or Metastatic Solid Tumors (The ADC MATCH Screening and Treatment Trial)
In reclutamentoFase 2
- University of Wisconsin Carbone Cancer Center - Eastpark Medical Center, Madison
- University of Wisconsin Carbone Cancer Center - University Hospital, Madison
Biomarkers to Detect Endocrine Therapy Resistance
In reclutamentoFase 2
- UW Carbone Cancer Center, Madison
Y-NM600 in Patients Receiving Anti-PD-1 or Anti-PD-L1 for Metastatic Cancer
In reclutamentoFase 1
- UW Carbone Cancer Center, Madison
FOG-001 in Locally Advanced or Metastatic Solid Tumors
In reclutamentoFase 1/2
- University of Wisconsin, Carbone Cancer Center, Madison
Studying the Safety and Determining the Optimal Dose of Novobiocin in Patients With Tumors That Have Alterations in DNA Repair Genes
In reclutamentoFase 1
- University of Wisconsin Carbone Cancer Center - Eastpark Medical Center, Madison
- University of Wisconsin Carbone Cancer Center - University Hospital, Madison
A Clinical Study of KTX-2001 in Subjects With Metastatic Castration-Resistant Prostate Cancer (STRIKE-001)
In reclutamentoFase 1
- University of Wisconsin, Madison
Veterans Affairs Seamless Phase II/III Randomized Trial of STAndard Systemic theRapy With or Without PET-directed Local Therapy for Oligometastatic pRosTate Cancer
In reclutamentoFase 2/3
- William S. Middleton Memorial Veterans Hospital, Madison, WI, Madison
A Randomized, Phase 2/3 Study to Investigate the Efficacy and Safety of RP2 in Combination With Nivolumab in Immune Checkpoint Inhibitor-Naïve Adult Patients With Metastatic Uveal Melanoma
In reclutamentoFase 2/3
- University Of Wisconsin Carbone Cancer Center - University Hospital, Madison
Study of TJ033721 (Givastomig) in Subjects With Advanced or Metastatic Solid Tumors
In reclutamentoFase 1
- UW Carbone Cancer Center, Madison
IFx-Hu2.0 As An Adjunctive Therapy To Pembrolizumab In Advanced Or Metastatic Merkel Cell Carcinoma (MCC)
In reclutamentoFase 1
- University of Wisconsin Carbone Cancer Center, Madison
Comparing Dosing Intervals of Nivolumab or Pembrolizumab in Locally Advanced or Metastatic Cancers
In reclutamentoFase 1
- SSM Health Cancer Care, Madison
In Vivo Liquid Biopsy of Melanoma (Cytophone)
In reclutamentoVolontari sani benvenuti
- SSM Health Dean Medical Group Specialty Services, Madison
Studi su Cancro metastatico in altre città
- Houston, TX104 studi
- New York City, NY93 studi
- Nashville, TN70 studi
- Boston, MA63 studi
- Los Angeles, CA57 studi
- St. Louis, MO54 studi
- Arlington, VA53 studi
- Philadelphia, PA46 studi
- Chicago, IL45 studi
- San Antonio, TX44 studi
- Washington, DC43 studi
- Dallas, TX42 studi
Altri studi a Madison
- Cancro alla prostata29 studi
- Cancro colorettale22 studi
- Cancro al seno22 studi
- Cancro del polmone non a piccole cellule16 studi
- Leucemia mieloide acuta16 studi
- Melanoma15 studi
- Cancro (tutti i tipi)14 studi
- Cancro ovarico13 studi
- Cancro dello stomaco11 studi
- Cancro ai polmoni10 studi
- Cancro pancreatico10 studi
- Mieloma multiplo9 studi
Fonte: ClinicalTrials.gov, dati recuperati il 5 ott 2026. Ogni studio stabilisce i propri criteri di idoneità; è il team di ricerca a decidere chi può partecipare.